We first demonstrated our ability to predictably shift analyte response curves with the growth/differentiation factor-15 (GDF-15) protein, which is a biomarker for inflammation, myocardial ischemia, and cancer19. This evidence concerns the gene GDF15 and myocardial ischemia.